相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Non-Invasive Imaging of Tumors by Monitoring Autotaxin Activity Using an Enzyme-Activated Near-Infrared Fluorogenic Substrate
Damian Madan et al.
PLOS ONE (2013)
Inhibiting Matrix Metalloproteinases, an Old Story with New Potentials for Cancer Treatment
Dimitris Stellas et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2012)
Chemical Evolution of Autotaxin Inhibitors
Harald M. H. G. Albers et al.
CHEMICAL REVIEWS (2012)
Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis In Vivo and Inhibition Enhances Anti-VEGF Therapy
Alan McIntyre et al.
CLINICAL CANCER RESEARCH (2012)
Carbamoylphosphonates Control Tumor Cell Proliferation and Dissemination by Simultaneously Inhibiting Carbonic Anhydrase IX and Matrix Metalloproteinase-2. Toward Nontoxic Chemotherapy Targeting Tumor Microenvironment
Reuven Reich et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Targeting Tumor Hypoxia: Suppression of Breast Tumor Growth and Metastasis by Novel Carbonic Anhydrase IX Inhibitors
Yuanmei Lou et al.
CANCER RESEARCH (2011)
Orally Active, Antimetastatic, Nontoxic Diphenyl Ether-Derived Carbamoylphosphonate Matrix Metalloproteinase Inhibitors
Julia Frant et al.
CHEMMEDCHEM (2011)
Interfering with pH regulation in tumours as a therapeutic strategy
Dario Neri et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
An in vitro Assay to Measure Targeted Drug Delivery to Bone Mineral
Wolfgang Jahnke et al.
CHEMMEDCHEM (2010)
Selective Matrix Metalloproteinase Inhibitors for Cancer
Nian-Guang Li et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Matrix metalloproteinase proteomics: substrates, targets, and therapy
Charlotte J. Morrison et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Lysophosphatidic acid (LPA) and its receptors
Kyoko Noguchi et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Fluorescence- and spin-labeled carbonic anhydrase inhibitors
Alessandro Cecchi et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran
NATURE REVIEWS DRUG DISCOVERY (2008)
The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis
RA Cardone et al.
NATURE REVIEWS CANCER (2005)
Carbarnoylphosphonate matrix meta iloproteinase inhibitors 3:: In vivo evaluation of cyclopentylcarbamoylphosphonic acid in experimental metastasis and angiogenesis
R Reich et al.
CLINICAL CANCER RESEARCH (2005)
Carbamoylphosphonate-based matrix metalloproteinase inhibitor metal complexes:: solution studies and stability constants.: Towards a zinc-selective binding group
[Anonymous]
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2004)
Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH
E Svastová et al.
FEBS LETTERS (2004)
Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors.: 1.: Alkyl- and cycloalkylcarbamoylphosphonic acids
E Breuer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer
CPS Potter et al.
BRITISH JOURNAL OF CANCER (2003)
The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2) involves a single catalytic site
R Gijsbers et al.
FEBS LETTERS (2003)
Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase
A Tokumura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
分享论文
